As of 2025-11-06, the Relative Valuation of Blueprint Medicines Corp (BPMC) is (35.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 129.46 USD, the upside of Blueprint Medicines Corp based on Relative Valuation is -127.4%.
The range of the Relative Valuation is (35.06) - (36.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 15.1x | 14.7x |
| Forward P/E multiples | 14.6x - 15.0x | 14.8x |
| Fair Price | (35.06) - (36.22) | (35.52) |
| Upside | -127.1% - -128.0% | -127.4% |
| Date | P/E |